Patents by Inventor Michael John Monteith

Michael John Monteith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide
    Patent number: 8314232
    Abstract: The present invention relates to a process of preparing a compound of the following formula III: wherein R1-R4 are as defined herein. The present invention also relates to the preparation of intermediates used to prepare the compound of formula III.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: November 20, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Nicole Marie Deschamps, Michael Tolar Martin, Michael John Monteith, Xiaoming Zhou
  • Pharmaceutical Formulations
    Publication number: 20100093866
    Abstract: The invention relates to the use of magnesium stearate to inhibit or reduce chemical degradation of an active ingredient substance in a formulation comprising a carrier in a solid pharmaceutical formulation, wherein the active ingredient substance is susceptible to chemical degradation.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 15, 2010
    Inventors: Michael John Monteith, Marian Thomas
  • Preparation of a Quinolinyloxydiphenylcyclopropanedicarboxamide
    Publication number: 20100081805
    Abstract: The present invention relates to a process of preparing a compound of the following formula III: wherein R1-R4 are as defined herein.
    Type: Application
    Filed: September 25, 2009
    Publication date: April 1, 2010
    Inventors: Nicole Marie Deschamps, Michael Tolar Martin, Michael John Monteith, Xiaoming Zhou
  • Phenethanolamine derivatives for treatment of respiratory diseases
    Patent number: 7442837
    Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: October 28, 2008
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Diane Mary Coe, Dean David Edney, Stephen Barry Guntrip, Abigail Halton, Brian Edgar Looker, Michael John Monteith, Rebecca Jane Moore, Rajnikant Patel, Panayiotis Alexandrou Procopiou
  • Methods using phenethanolamine derivatives for treatment of respiratory diseases
    Patent number: 7442719
    Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Grant
    Filed: August 19, 2005
    Date of Patent: October 28, 2008
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Diane Mary Coe, Dean David Edney, Stephen Barry Guntrip, Abigail Halton, Brian Edgar Looker, Michael John Monteith, Rebecca Jane Moore, Rajnikant Patel, Panayiotis Alexandrou Procopiou
  • Phenethanolamine derivatives for treatment of respiratory diseases
    Patent number: 7442836
    Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: October 28, 2008
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Diane Mary Coe, Dean David Edney, Stephen Barry Guntrip, Abigail Halton, Brian Edgar Looker, Michael John Monteith, Rebecca Jane Moore, Rajnikant Patel, Panayiotis Alexandrou Procopiou
  • Agonists of beta-adrenoceptors
    Patent number: 7144908
    Abstract: The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: December 5, 2006
    Assignee: Glaxo Group Limited
    Inventors: Diane Mary Coe, Michael John Monteith, Panayiotis Alexandrou Procopiou
  • Agonists of beta-adrenoceptors
    Publication number: 20040242890
    Abstract: The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Application
    Filed: March 5, 2004
    Publication date: December 2, 2004
    Inventors: Diane Mary Coe, Michael John Monteith, Panayiotis Alexandrou Procopiou
  • Phenethanolamine derivatives for treatment of respiratory diseases
    Publication number: 20040180876
    Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
    Type: Application
    Filed: February 9, 2004
    Publication date: September 16, 2004
    Inventors: Keith Biggadike, Diane Mary Coe, Dean David Edney, Stephen Barry Guntrip, Abigail Halton, Brian Edgar Looker, Michael John Monteith, Rajnikant Patel, Panayiotis Alexandrou Procopiou
  • Process for the preparation of butane triols
    Patent number: 6479714
    Abstract: A process for the preparation of butane triols is provided. In the process, a malic acid diester is reduced with sodium borohydride in the presence of an ether and an alcohol. Preferably, the malic acid diester is an ethyl or methyl ester, the ether is tetrahydrofuran or bis(2-methoxyethyl) ether (diglyme), and the alcohol comprises ethanol. Advantageously, the reaction is carried out at ambient temperature.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: November 12, 2002
    Assignee: Avecia Limited
    Inventors: David Schofield, Mark Bailey, Michael John Monteith
  • Process for the preparation of 2-hydroxyalkyl halophenones
    Patent number: 6362376
    Abstract: 2-Benzyloxyalkyl halophenones of the formula (3): wherein X1 and X2 are each independently H, Cl or F, provided that at least one of X1 and X2 is Cl or F; one of R3 and R4 is H and the other is optionally substituted benzyloxy; and R5 is an unsubstituted alkyl, preferably a C1-6 alkyl group. The compounds are useful as intermediates for preparing 2-hydroxyalkyl halophenones.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: March 26, 2002
    Assignee: Avecia Limited
    Inventors: John Crosby, Kevin Douglas Bailey, Michael John Monteith
  • Process for the preparation of 2-hydroxyalkyl halophenones
    Patent number: 6300522
    Abstract: A process is provided for the preparation of compounds of Formula (1): wherein X1 and X2 are each independently H, Cl or F, provided that at least one of X1 and X2 is Cl or F; one of R1 and R2 is H and the other is OH; and R5 is an unsubstituted alkyl, preferably a C1-6 alkyl, group.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: October 9, 2001
    Assignee: Avecia Limited
    Inventors: John Crosby, Kevin Douglas Bailey, Michael John Monteith
  • Process for the preparation of substituted aromatic compounds
    Patent number: 6218564
    Abstract: A process for the preparation of a substituted aromatic compound in which a chloroaromatic compound and an alkyl-, alkenyl- or aryl-boronic acid ester or anhydride are coupled in the presence of palladium and a lipophilic aliphatic phosphine comprising at least one branched aliphatic group or a lipophilic aliphatic Dis(phosphine). Preferred phosphines include triisopropyl, triisobutyl and tricyclohexylphosphine.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: April 17, 2001
    Assignee: Zeneca Limited
    Inventor: Michael John Monteith